Inflammatory Bowel Disease Clinical Trials

73 recruiting

Inflammatory Bowel Disease Trials at a Glance

200 actively recruiting trials for inflammatory bowel disease are listed on ClinicalTrialsFinder across 6 cities in 54 countries. The largest study group is Not Applicable with 58 trials, with the heaviest enrollment activity in New York, Boston, and London. Lead sponsors running inflammatory bowel disease studies include Massachusetts General Hospital, Changhai Hospital, and McMaster University.

Browse inflammatory bowel disease trials by phase

Treatments under study

About Inflammatory Bowel Disease Clinical Trials

Looking for clinical trials for Inflammatory Bowel Disease? There are currently 73 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Inflammatory Bowel Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Inflammatory Bowel Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 200 trials

Recruiting
Phase 2

FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

Inflammatory Bowel DiseasesPrimary Sclerosing Cholangitis
University of Birmingham58 enrolled5 locationsNCT06286709
Recruiting
Not Applicable

Combining Nutritional Therapy and Anti-TNFα Treatment in Pediatric Patients With Crohn's Disease

IBD (Inflammatory Bowel Disease)Crohn Disease (CD)
University of British Columbia140 enrolled1 locationNCT07314606
Recruiting

ALPCO Calprotectin CLIA Assay - Measurement of Calprotectin Levels in Human Stool

Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)Inflammatory Bowel Syndrome
American Laboratory Products Company220 enrolled3 locationsNCT06810518
Recruiting
Not Applicable

IBD-Sleep: A Pilot Study Looking at Changes in Sleep Timing and IBD Symptoms

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
University of Michigan68 enrolled1 locationNCT06094608
Recruiting
Phase 2

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

ColitisInflammatory Bowel DiseasesUlcerative Colitis
Spyre Therapeutics, Inc.645 enrolled175 locationsNCT07012395
Recruiting

Predictors of Prognosis in IBD Patients

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis
Seoul National University Bundang Hospital100 enrolled1 locationNCT05653011
Recruiting

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis+9 more
Seattle Children's Hospital200 enrolled1 locationNCT06315179
Recruiting
Phase 1

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Malignant Solid NeoplasmHematopoietic and Lymphoid Cell NeoplasmRheumatoid Arthritis+11 more
National Cancer Institute (NCI)300 enrolled52 locationsNCT03816345
Recruiting

Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients

ColonoscopyIBD (Inflammatory Bowel Disease)
Changhai Hospital1,000 enrolled1 locationNCT07335705
Recruiting
Not Applicable

Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease

ColonoscopyIBD (Inflammatory Bowel Disease)
Changhai Hospital1,000 enrolled1 locationNCT07353853
Recruiting
Phase 3

A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)

Inflammatory Bowel DiseasesCrohn's DiseaseUlcerative Colitis+1 more
Eli Lilly and Company150 enrolled66 locationsNCT04844606
Recruiting
Phase 2

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Inflammatory Bowel DiseasesCrohn's Disease
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)385 enrolled215 locationsNCT06226883
Recruiting
Phase 2

Study of DISC-0974-201 in Participants With IBD and Anemia

AnemiaInflammatory Bowel Disease (IBD)Inflammatory Bowel Disease (IBD); Anemia
Disc Medicine, Inc21 enrolled8 locationsNCT07368972
Recruiting

COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)

Inflammatory Bowel DiseasesCrohn DiseaseUlcerative Colitis, Pediatric
University of North Carolina, Chapel Hill1,100 enrolled4 locationsNCT07198113
Recruiting

Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study

Inflammatory Bowel Diseases
Nanfang Hospital, Southern Medical University420 enrolled1 locationNCT07539727
Recruiting
Phase 2

Pentoxifylline in Patients With Ulcerative Colitis

Inflammatory Bowel Diseases
Ihab Elsayed Hassan60 enrolled1 locationNCT07349472
Recruiting

A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disease in the United Kingdom (UK)

Inflammatory Bowel Disease
Janssen-Cilag Ltd.220 enrolled1 locationNCT07242248
Recruiting
Phase 1

A Phase 1 Study of PVT401 in Healthy Subjects

Inflammatory Bowel Disease (IBD)
Parvus Therapeutics, Inc.36 enrolled1 locationNCT07423000
Recruiting

A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany

Inflammatory Bowel Disease
Janssen-Cilag G.m.b.H400 enrolled1 locationNCT07102368
Recruiting

A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea

Inflammatory Bowel Diseases
Janssen Korea, Ltd., Korea8,000 enrolled1 locationNCT07520747